Market Forecast By Drug Type (Prescription Drugs, OTC Drugs), By Type ( Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consulting Pharmacy, Ambulatory Care Pharmacy, Others) And Competitive Landscape
Product Code: ETC036174 | Publication Date: Jun 2023 | Updated Date: Dec 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Report Name | Myanmar Pharmacies and Drug Stores market |
Forecast period | 2024-2030 |
Forecast size | USD 850 Million – USD 1100 Million |
CAGR | 7.4% |
Growing Sector | Healthcare |
The Myanmar Pharmacies and Drug Stores market report thoroughly covers the market by drug type and by type. The report provides an unbiased and detailed analysis of the on-going market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
In 2024, the Myanmar Pharmacies and Drug Stores market is valued at approximately $ 850 million, with a projected compound annual growth rate (CAGR) of 7.4% over the next five years. Additionally, by 2030, the market is expected to reach around $ 1100 million. The healthcare sector holds significant position in the overall market.
The Myanmar pharmacies and drug stores market is experiencing gradual growth, fueled by an expanding healthcare sector, increasing urbanization, and rising health awareness among the population. With the country's economic development and a growing middle class, demand for both prescription and over-the-counter (OTC) medications is on the rise, especially in major cities like Yangon and Mandalay. The market is benefiting from the expansion of modern retail pharmacy chains and an improving pharmaceutical supply chain.
Additionally, the government is working to enhance healthcare access, which, along with growing foreign investment, is contributing to the market's development. However, challenges such as regulatory issues, limited infrastructure in rural areas, and the presence of counterfeit medicines continue to pose obstacles to growth. Despite these challenges, the market is expected to expand steadily in the coming years, driven by improved healthcare access and economic growth.
According to 6Wresearch, Myanmar Pharmacies and Drug Stores market size is projected to grow at a CAGR of 7.4% during 2024-2030. The growth of the Myanmar pharmacies and drug stores market is primarily driven by an expanding middle class, greater urbanization, and increasing health awareness, leading to higher demand for both prescription and over-the-counter medications. The rising prevalence of chronic diseases, along with a growing focus on preventive healthcare, is contributing to the demand for pharmaceutical products. The expansion of modern retail pharmacy chains and improved healthcare infrastructure, particularly in urban areas, are further fueling market growth.
Additionally, foreign investments in the healthcare sector and government initiatives to improve access to medicines and healthcare services are significant drivers. However, the Myanmar Pharmacies and Drug Stores industry faces challenges such as inconsistent regulatory enforcement, the presence of counterfeit medicines, and limited infrastructure in rural areas, which can hinder the full potential of market growth. The ongoing political instability and economic challenges in the country also pose risks to investment and long-term market stability.
Key companies in Myanmar’s pharmacies and drug stores market include both local and international players, with major names such as City Drug Store, one of the largest pharmacy chains in the country, providing a wide range of medications and health products across multiple locations. Yatanarpon Drug Store, a prominent local pharmacy, also has a significant presence in the retail sector, offering prescription and over-the-counter drugs. International chains like Guardian Myanmar, part of the Malaysian-based Guardian Group, are expanding their footprint in urban areas, bringing a diverse range of pharmaceutical products and health services. Pharmacy 7 is another notable player, serving both retail and wholesale pharmaceutical needs.
Additionally, some of these players hold majority of the Myanmar Pharmacies and Drug Stores market share. Moreover, these companies are at the forefront of driving market growth, offering a combination of retail pharmacy services, online platforms, and strong distribution networks, while navigating the challenges posed by local regulatory issues and counterfeit drug concerns.
The government of Myanmar regulates the pharmaceutical sector through the Ministry of Health, which oversees the import, manufacturing, distribution, and sale of drugs in the country. The Myanmar Food and Drug Administration (FDA) plays a key role in ensuring that pharmaceuticals meet safety, quality, and efficacy standards, while also combating the issue of counterfeit medicines through stricter enforcement measures.
Further, these initiatives have further boosted the Myanmar Pharmacies and Drug Stores market revenues. Further, regulations require pharmacies to operate with a licensed pharmacist and adhere to specific guidelines for storing and dispensing medications. In recent years, the government has been working to strengthen the regulatory framework, improve drug registration processes, and enhance drug safety monitoring.
The future of Myanmar’s pharmacies and drug stores market holds strong growth potential, driven by ongoing improvements in healthcare infrastructure, increasing urbanization, and a rising middle class with greater access to healthcare services. The demand for both prescription and over-the-counter medications is expected to continue growing, fueled by an aging population and an increase in chronic diseases. With the expansion of retail pharmacy chains, the rise of e-commerce platforms, and a focus on improving drug safety and regulatory standards, the market is set for transformation.
Additionally, advancements in pharmacy technology, including digital solutions for pharmacy management and online consultations, will play a pivotal role in enhancing operational efficiency and consumer access to healthcare.
According to Ravi Bhandari, Research Head, 6Wresearch, the prescription drugs category in Myanmar is poised for robust growth, driven by an increasing prevalence of chronic diseases such as hypertension, diabetes, and cardiovascular conditions, as well as rising demand for specialized treatments. With greater access to healthcare facilities and a growing middle class, more individuals are seeking medical attention and prescription medications. Additionally, the expanding healthcare infrastructure, along with an increase in hospital admissions and outpatient care, is further boosting the demand for prescription drugs. As the population ages and awareness of health issues improves, the prescription drug market is expected to see a shift toward higher-value treatments, including biologics and specialty medications, contributing to significant growth in the coming years.
The hospital pharmacy segment in Myanmar is set to experience significant growth, driven by the expansion of healthcare facilities, particularly in urban areas, and an increasing number of hospital admissions. As the healthcare system continues to develop, hospital pharmacies are expected to play a crucial role in dispensing specialized medications for chronic disease management, surgical care, and oncology treatments. With a rising demand for advanced therapies and medications, hospital pharmacies will also focus on improving their service delivery through better drug management systems, automation, and integration of digital health solutions. This growth will be further supported by government initiatives to enhance healthcare access, improve the quality of care, and address the needs of an aging population, thus ensuring that hospital pharmacies remain a central component in Myanmar’s evolving healthcare landscape.
The Myanmar Pharmacies and Drug Stores market report provides a detailed analysis of the following market segments -
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Myanmar Pharmacies and Drug Stores Market Overview |
3.1 Myanmar Country Macro Economic Indicators |
3.2 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, 2020 & 2030F |
3.3 Myanmar Pharmacies and Drug Stores Market - Industry Life Cycle |
3.4 Myanmar Pharmacies and Drug Stores Market - Porter's Five Forces |
3.5 Myanmar Pharmacies and Drug Stores Market Revenues & Volume Share, By Drug Type, 2020 & 2030F |
3.6 Myanmar Pharmacies and Drug Stores Market Revenues & Volume Share, By Type, 2020 & 2030F |
4 Myanmar Pharmacies and Drug Stores Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Myanmar Pharmacies and Drug Stores Market Trends |
6 Myanmar Pharmacies and Drug Stores Market, By Types |
6.1 Myanmar Pharmacies and Drug Stores Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Drug Type, 2020 - 2030F |
6.1.3 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Prescription Drugs, 2020 - 2030F |
6.1.4 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By OTC Drugs, 2020 - 2030F |
6.2 Myanmar Pharmacies and Drug Stores Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Community Pharmacy, 2020 - 2030F |
6.2.3 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Hospital Pharmacy, 2020 - 2030F |
6.2.4 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Clinical Pharmacy, 2020 - 2030F |
6.2.5 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Industrial Pharmacy, 2020 - 2030F |
6.2.6 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Compounding Pharmacy, 2020 - 2030F |
6.2.7 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Consulting Pharmacy, 2020 - 2030F |
6.2.8 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2020 - 2030F |
6.2.9 Myanmar Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2020 - 2030F |
7 Myanmar Pharmacies and Drug Stores Market Import-Export Trade Statistics |
7.1 Myanmar Pharmacies and Drug Stores Market Export to Major Countries |
7.2 Myanmar Pharmacies and Drug Stores Market Imports from Major Countries |
8 Myanmar Pharmacies and Drug Stores Market Key Performance Indicators |
9 Myanmar Pharmacies and Drug Stores Market - Opportunity Assessment |
9.1 Myanmar Pharmacies and Drug Stores Market Opportunity Assessment, By Drug Type, 2020 & 2030F |
9.2 Myanmar Pharmacies and Drug Stores Market Opportunity Assessment, By Type, 2020 & 2030F |
10 Myanmar Pharmacies and Drug Stores Market - Competitive Landscape |
10.1 Myanmar Pharmacies and Drug Stores Market Revenue Share, By Companies, 2023 |
10.2 Myanmar Pharmacies and Drug Stores Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |